EZH2 and hepatocellular carcinoma: Findings from in vitro studies also affirm that curcumin can upregulate the enhancer of zeste homolog 2 (EZH2) breast cancerous cells and downregulate deletion gene 1(DLC1) in hepatocellular carcinoma.